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Abstract
Objectives: There is a pressing need to understand the challenges surrounding procurement of and business case
development for hospital electronic prescribing systems, and to identify possible strategies to enhance the efficiency of
these processes in order to assist strategic decision making.
Materials and Methods: We organized eight multi-disciplinary round-table discussions in the United Kingdom. Participants
included policy makers, representatives from hospitals, system developers, academics, and patients. Each discussion was
digitally audio-recorded, transcribed verbatim and, together with accompanying field notes, analyzed thematically with
NVivo9.
Results: We drew on data from 17 participants (approximately eight per roundtable), six hours of discussion, and 15 pages
of field notes. Key challenges included silo planning with systems not being considered as part of an integrated
organizational information technology strategy, lack of opportunity for interactions between customers and potential
suppliers, lack of support for hospitals in choosing appropriate systems, difficulty of balancing structured planning with
flexibility, and the on-going challenge of distinguishing ‘‘wants’’ and aspirations from organizational ‘‘needs’’.
Discussion and conclusions: Development of business cases for major investments in information technology does not
take place in an organizational vacuum. Building on previously identified potentially transferable dimensions to the
development and execution of business cases surrounding measurements of costs/benefits and risk management, we have
identified additional components relevant to ePrescribing systems. These include: considerations surrounding strategic
context, case for change and objectives, future service requirements and options appraisal, capital and revenue
implications, timescale and deliverability, and risk analysis and management.
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Introduction
Hospital electronic prescribing (henceforth referred to as
ePrescribing) systems are being implemented by healthcare
organizations in an attempt to improve the safety, quality, and
efficiency of the medication use process [1–4]. In the United
Kingdom (UK), these are commonly understood as systems
designed to facilitate the processes of medication prescribing,
ordering, transmitting, dispensing, administering, and monitoring.
Such systems are being increasingly considered and implement-
ed in much of the economically-developed world, especially in the
United States (US), where computerized prescribing in hospitals is
a key requirement in achieving meaningful use [5]. The pace of
implementation has been slower in other countries – including the
UK – but the challenges faced are often similar. For example,
implementations are often associated with significant changes to
organizational functioning and ways of working [6,7].
As with any large organizational change initiative involving a
major financial outlay, business cases are utilized to outline the
underlying reasoning for ePrescribing implementations, including
expected investments, benefits and timeframes [8]. This typically
also includes the justification for desired changes tailored to
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individual organizational factors and is sometimes presented as an
argument to obtain management commitment for the desired
change [9]. However, variations in organizational contexts and
needs complicate work in this area [9], this being compounded by
a lack of robust empirical efforts systematically addressing key
concepts and processes [9], and limited experience of adapting
business cases over longer periods of time [10].
At present, decisions are often largely based on anticipated
direct financial savings (or proxies to these such as improved
efficiency and safety), which are then weighed against the costs of
implementation or of achieving such improvements through other
means. If the anticipated benefits outweigh the costs, the
assumption is that the hospital will become more efficient.
Business cases in the UK typically follow a specific format and
this same format is used within the National Health Service (NHS)
[10]. For example, the NHS Technology Adoption Centre in the
UK, a national governmental body tasked with helping healthcare
organizations to implement technological change, suggests core
components of a business case (Table 1) [11].
There are however a number of practical challenges to
developing ePrescribing business cases within the NHS. These
include, but are not limited to: a lack of change management
expertise; varying organizational contexts; the relative immatu-
rity of the supplier market with a wide range of available systems
with different functionalities (particularly in hospital settings),
but rather limited implementation experience of most systems;
the complexity of change associated with the introduction of
electronic systems which also results in difficulties measuring
benefits; and the fact that many systems do not include tools
which can help to track benefits after implementation [12–14].
Although these applications are nearly always bundled with
other types of ordering in the US, such an approach is not yet
common in the UK.
Building on earlier work focusing on primary care [7,15–17],
we have been commissioned to undertake a national evaluation
of hospital ePrescribing systems within NHS England [18]. As
part of this work, we are developing a toolkit to support and
guide organizations through their implementation journey [19].
In this paper, we present findings from a series of national
interactive multi-disciplinary round-table discussions aiming to
understand the challenges surrounding procurement and
business case development, and identify possible strategies to
facilitate associated commercial processes based on the
findings.
Materials and Methods
Ethics and consent
This work was classed as a service evaluation by the London
City & East Research Ethics Committee. We supplied an
information sheet to each participant detailing the aims of the
study on the day of the event. Written consent to take part was
obtained from each participant, comprising a signed consent
form. All participants were encouraged to discuss any questions
with the research team prior to data collection. The primary
goal of the round-table discussions was for participants to
exchange experiences, but they were made aware that their
anonymous comments would be included in a peer-reviewed,
publicly accessible journal.
Design
We conducted a one-day event including a series of
sequential, multi-disciplinary round-table discussions with two
parallel groups considering the same topics (see Table 2).
Participants were divided into two groups and each group
participated in four group discussions (each ,45 minutes in
length amounting to a total of six hours) with designated
facilitators to explore different perspectives and dynamics as
well as potential ways to align interests [20].
Participants
Participants came from a diverse range of stakeholders who had
an interest and/or experience in implementing ePrescribing
systems in the UK. They were purposefully sampled for maximum
variation to include representatives from a variety of sectors
including: hospitals that had recently implemented, hospitals in the
planning phase, system developers, policy makers, academics, and
patients [20].
For sampling, we developed a database of over 400 individuals
based in the UK with a potential interest in implementing or
adopting ePrescribing systems [18]. This database was based on
existing professional networks, contacts from previous related
academic research projects, and targeted searches of online
conference databases to identify potentially interested delegates.
We sent a message with the overall aim of the roundtable
discussions to all contacts, inviting interested parties to get in touch
with the lead researcher (KC). A total of 47 individuals expressed
interest in participating. All of these individuals were sent a draft
agenda and asked to add other potentially important items as well
as confirm their attendance. All participants that were interested
were invited to the event, but we ensured that we had only one
Table 1. Core components of a business case [11].
Component
Executive Summary
Strategic Context
Case for Change
Objectives
Future Service Requirements
Options Appraisal
Capital Implications
Revenue Implications
Preferred Option
Affordability
Timescale and Deliverability
Risk Analysis and Management
Conclusion
doi:10.1371/journal.pone.0079394.t001
Table 2. Key issues explored in the multi-disciplinary round-
table discussions.
Conceptualization and project initiation (in two groups)
Topic 1: What are the main issues to consider before project initiation?
Topic 2: What are the main aspects involved in project initiation?
Functional specification and drafting a business case (in two groups)
Topic 3: How to assess available options in terms of the product?
Topic 4: What are the main challenges involved in drafting a business case?
doi:10.1371/journal.pone.0079394.t002
Business Case for Hospital Electronic Prescribing
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representative from each hospital attending in order to maximize
the range of perspectives.
We also strategically targeted specific individuals that were
from under-represented areas. These were included in our
initial database, but did not respond to us inviting initial
expressions of interest. For example, we needed to draw on our
personal contacts to get representatives from hospitals that had
already implemented systems (in order to draw on a range of
experiences from hospitals at different stages of implementa-
tion), as this event was viewed as being of limited value to such
individuals. Overall, 12 participants were recruited through our
initial efforts and we invited an additional five participants from
our personal contacts.
Setting
The roundtable discussions took place in Birmingham, UK in
October 2012 [18].
Data collection and handling
Before the roundtable discussions, participants were divided into
two groups ensuring maximum representation of different
stakeholders in each. Both groups were allocated a moderator
(ASl and JC), who led the discussion ensuring focus of discussions
and equal input by participants. The day had two main thematic
components: 1) conceptualizing and planning implementation (see
topics 1 and 2 Table 2); and 2) specifying system functionality and
drafting a business case (topics 3 and 4, Table 2).
Each topic was allocated approximately 45 minutes. Each
thematic part was followed by group discussion during which the
two groups exchanged main areas discussed in a plenary session.
The plenary sessions consisted of presentation of overall discussion
points by the facilitators, followed by participants discussing
similarities and differences between groups and adding additional
thoughts/comments.
In the interest of maintaining confidentiality and anonymity,
participant professional roles and locations were anonymized by
assigning broad categories and numbers.
Each group discussion was audio-recorded and transcribed. In
addition, designated researchers (KC and RP) took field notes
relating to perceived dynamics and interactions between partic-
ipants.
Data analysis
Transcribed data for each topic and group were uploaded into
NVivo9 software (a qualitative data analysis software that allows
organizing textual data) to facilitate coding. This was initially done
along the four topic areas, followed by thematically coding
emerging themes inductively [21,22]. Emerging findings were then
discussed within the wider research team leading to the refinement
of categories [23]. Areas that were repeatedly identified across
different stakeholder groups as either being a subject of tension or
agreement were explored in most detail.
We drew on a lifecycle perspective of technology implementa-
tion in analyzing the data and conceptualized the business case
stage as part of the beginning of the journey towards full
ePrescribing implementation [18,24,25]. This was complemented
by drawing on a theoretical approach that we have developed and
refined in previous work to guide data collection and analysis
activities [26,27]. This provides a structure for examining different
aspects of the lifecycle of ePrescribing implementation situated
within the macro-context of a large, dynamic national health
system. Our findings were then organized along the business case
components outlined in Table 1.
Results
Drawing on data from 17 participants, our complete dataset
comprised eight audio-recordings lasting six hours and 15 pages of
researcher field notes. Participants included nine representatives
from hospitals at various stages of implementation, four system
developers, two policy representatives, one patient, and one
academic (Table 3).
Overall, benefits of systems that were viewed as realistic
amongst participants included the following:
N Reductions in prescribing errors and improved patient safety
through decision support functionality and legibility;
N Improved quality of care through improved access to
information and information flow;
N Improved guideline implementation and compliance;
N Secondary uses of data (e.g. audits, among many others).
We identified the following overarching themes:
N Strategic context: considering the implementation of ePre-
scribing as part of a wider organizational strategic develop-
ment.
Table 3. Participant characteristics.
GROUP 1 GROUP 2
1 Male Female
Policy Policy
2 Female Male
Physician Pharmacist
Hospital planning to
implement
Hospital planning to
implement
3 Male Female
Project Manager Project Manager
Hospital in process of
implementing
Hospital in process of
implementing
4 Male Female
Pharmacist Pharmacist
Hospital planning to
implement
Hospital has implemented
5 Male Female
Pharmacist Pharmacist
Hospital in process of
implementing
Hospital has implemented
6 Male Female
System developer Nurse
Hospital planning to
implement
7 Male Male
System developer System developer
8 Male Male
Academic System developer
9 Female
Patient
doi:10.1371/journal.pone.0079394.t003
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N Case for change and objectives: developing and maintaining
relationships between customers and system suppliers through-
out procurement and implementation.
N Future service requirements and options appraisal: choosing
systems based on functional specifications and drawing on
experiences of other hospitals.
N Timescale and deliverability: planning the change whilst
maintaining strategic flexibility to respond to changing needs
and environments.
N Timescale and deliverability: separating ‘‘wants and aspira-
tions’’ from organizational needs.
These are summarized in Table 4 with detailed sub-themes and
will be discussed in turn with supporting illustrative quotes from
the data.
Strategic context: considering the implementation of
ePrescribing as part of a wider organizational strategic
development
High-level strategic direction and support from senior
organizational stakeholders were viewed as important pre-
requisites for implementing ePrescribing systems as they were
believed to affect many different aspects of organizational
functioning. Senior commitment was perceived to be essential in
ensuring the availability of necessary financial resources to
support implementation, maintaining project momentum, and
coordinating efforts across the organization to improve overall
business processes.
It’s a hospital wide system isn’t it, it’s deployed right across the hospital
so in some senses the ownership must sit with the top tier of management
within the hospital…it’s a system that’s going to interconnect with so
many other components of the electronic patient record so I think it’s got
to be owned at that level. (Group 2, Male, System developer)
Participants stated that ideally this high-level ownership should
be characterized by the ‘‘hands-on’’ involvement of senior hospital
staff in order to ensure that the implementation remained an
organizational priority over time. This was perceived to be
facilitated by integrating ePrescribing as an essential component of
the overall organizational information strategy.
…it’s part of the information strategy, with the current financial
situation it’s how it fits into the organizational strategy generally, it’s
not just IT [information technology] or information it’s ‘‘is this a
priority for the organization? Is it something that is fundamental about
how the organization does business?’’ (Group 1, Male, Pharmacist,
hospital planning to implement)
Participants discussed two different common conceptualizations
of this overall organizational information strategy. Firstly, imple-
mentation of IT could be viewed as an opportunity to
Table 4. Themes and sub-themes emerging from the data.
Strategic context: ePrescribing as part of a wider organizational strategy
- High-level drive and support from senior organizational stakeholders
- Inter-disciplinary involvement
- ePrescribing as an essential component of the overall organizational information strategy
- Organizational information strategies and associated ePrescribing system choices
Case for change and objectives: developing and maintaining relationships between customers and system suppliers
- Relationship building before and throughout the implementation journey
- A long-term partnership characterized by mutual trust but restrained by commercial relationships
- Sharing experiences of systems and suppliers through reference sites, supplier days and informal networks
Future service requirements and options appraisal: system choice through functional specifications and shared experiences
- Systems choice guided by functional specifications and networking with sites that have implemented
- Minimum system functions and outcome based specifications
- Restrictions in system choice and financial restrictions
- Pooling resources and sharing experiences
Timescale and deliverability: planning the change whilst maintaining strategic flexibility
- Workflow and process mapping
- Stakeholder engagement
- Investment and resources
- Parallel systems and interoperability
- Composition of the project team
- Journey as opposed to a project
- Changing needs and flexibility in strategy
Timescale and deliverability: separating ‘‘wants and aspirations’’ from organizational needs
- Expectations often exceed reality
- Organizational versus individual benefits
- Wishes versus needs
doi:10.1371/journal.pone.0079394.t004
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fundamentally change existing ways of working and business
processes. This was often stated to be associated with the hardest
work, but also the biggest potential benefits. Secondly, an
organizational information strategy could be viewed as a project
designed to enhance existing business processes. This approach
was seen to require less radical change and be easier to ‘‘sell’’ to
stakeholders as changes to individual ways of working were
perceived to be less fundamental. Participants stated that benefits
would be quicker to realize, but also tended to be more limited
than those associated with process changes in radical business
process re-design.
Most hospitals do not perceive their hospital based project to be a way of
radically changing the way they work as an organization or treat
patients as a process. They see it as an initiation of an IT system or a
new theatre or a new hospital wing or whatever project it is they’re
doing, it’s an enhancement to existing ways of doing things rather than
an opportunity for radical change. So when you think about strategy it
really depends on what level it’s set and what you perceive strategy to
be…(Group 2, Male, System developer)
These two ways to conceptualize organizational information
strategies were associated with different ePrescribing system
choices: integrated systems were more commonly seen to be part
of a fundamental business change strategy, whilst ‘‘stand-alone’’
ePrescribing systems (prescribing administration systems or those
integrated with a pharmacy stock control system) were seen to be
associated with strategies to enhance existing processes. As a result,
there were therefore at least two different types of business cases
for ePrescribing systems, each with very different resource
implications, ownership and expected benefits.
Case for change and objectives: developing and
maintaining relationships between customers and
system suppliers throughout procurement and
implementation
No matter what the organizational strategy, all stakeholders
agreed that establishing and maintaining good relationships
between hospitals and system suppliers was a pre-requisite to
any successful implementation journey. However, this was not
always encouraged and was hindered by existing tendering
processes that tended to promote ‘‘arm’s length’’ relationships in
the early stages. Relationship building with a range of suppliers
should ideally start long before the signing of a formal business
case, in order to understand what systems and system suppliers
offered and how products would fit in with organizational
processes and future plans.
The recognition that both suppliers and customers were
entering a long-term working partnership which should ideally
be characterized by open and honest dialogue was critical. In
doing so, both should have similar underlying visions and values
(as far as possible with one public service body and one
commercial entity), as well as a common desire to succeed and
develop together over time to meet new emerging challenges.
…most system vendors should be saying that they want to work in
partnership with the NHS…it’s not just about a two year thing or a
three year project it’s a longer term project so as part of that you have to
also make sure that any organization you’re working with is also aligned
to your organizational values…or just as wedded to actually achieving a
successful implementation at the end of it…(Group 1, Male, System
developer)
Trust was viewed to be a necessary component of the
relationship between customers and suppliers. Examples here
included trust in that both parties were getting benefits from
working together and that nobody was being ‘‘ripped off’’, but also
trust on the part of the customer that the necessary functionality
would be delivered by the developer.
…the process doesn’t really allow you to get to know the suppliers well
enough to know if you can trust them and vice versa…that long term
relationship with the system supplier and it colors everything so…the
mutual trust that you have so that suppliers don’t feel they’re getting
ripped off and we don’t feel we’re getting ripped off. Where things have
not gone well often it comes back to that and it’s a war of attrition.
(Group 1, Female, Physician, Hospital planning to implement)
An important aspect of engagement activity between suppliers
and customers was viewed to be open and honest discussion of
expectations and system capabilities, including potential limita-
tions and risks, on both sides. Ideally, this should be coupled with
system demonstrations/networking in/with sites that had already
implemented relevant systems and going through test scenarios
incorporating specific organizational needs. This was perceived to
help hospitals apply system functionalities to their own organiza-
tional processes and see the potential benefits of a fully functioning
system.
In addition to formal reference sites recommended by suppliers
(which might be expected to give a ‘rosy’ picture of benefits and
challenges), hospital staff stated that relying on informal personal
and professional networks was important to obtain insights into the
challenges experienced with a particular supplier, and also to
explore potential benefits and approaches to successfully working
with them. Informal networks were generally supported as they
were perceived to have a positive influence on system choice, but
unanticipated issues were mentioned in relation to formal
networks.
But then that’s a challenge because if those reference sites receive certain
discounts or support because they’re prepared to be reference sites…does
that then slightly temper what they may or may not be prepared to say?
(Group 2, Female, Pharmacist, hospital has implemented)
Future service requirements and options appraisal:
choosing systems based on functional specifications and
drawing on experiences of other hospitals
Participants stated that actual systems choice should be guided
by functional specifications. NHS Connecting for Health, an arms-
length governmental body charged with overseeing the imple-
mentation of national eHealth systems in England, had done
important groundwork in this respect, but the national strategy
was abolished in 2011 along with NHS Connecting for Health
[28]. Participants argued that such functional specifications should
be based on local needs, and by visiting sites that had already
implemented in order to gain an insight into the practical use of
the system for clinical management as well as processes associated
with implementation and planning. However, hospital represen-
tatives stated that the difficulty surrounding learning from other
sites was the fact that every organizational starting point and needs
differed significantly; for example how a new system would inter-
operate with existing systems and management processes. Suppli-
ers on the other hand felt that hospital processes did not vary as
much as some hospital stakeholders thought.
Business Case for Hospital Electronic Prescribing
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All agreed that the first step relating to systems choice should be
an assessment of the current status quo (in terms of existing
processes and systems), a mapping-out of the desired future
state, and consideration of the steps to get there. An outline of
minimum system functions (including safety standards) and
desired outcomes was viewed to be a necessary part of this
process. Outcome-based specifications (defined as specifications
based on the functional requirements for the proposed
development without addressing how those outputs may be
achieved) were seen as a means for customers and suppliers to
achieve a common goal, but it was also acknowledged that such
specifications were open to interpretation and could mean
different things to different stakeholders.
…that’s the difference though is that the OBS [outcome-based
specification] is what the outcome is, not how it does it. Because…you
can write on the spec it must have a single sign on but the OBS will be
that you must have security. So that’s why the OBS I would think is a
better way…because it’s not that level of detail but that’s uncomfortable
for the [hospital] because I want it to exactly, to do this rather than it
needs to be able to deliver this. (Group 1, Male, Pharmacist, hospital
planning to implement)
Similarly, detailed functional specifications were seen as
necessary to detail specific processes, but participants also
recognized the inherent tension between tight functional specifi-
cations (which were often aspirational) and associated restrictions
in systems choice, suppliers and innovation which may have a
detrimental effect on the tendering process.
…there are different ways to procure things nowadays and therefore a lot
of the procurement approach is going to be things like restricted energies
where you’re producing a very tight specification so you’re not necessarily
going out to do anything like competitive dialogue…(Group 1, Male,
Policy)
…on that supplier day there were only two suppliers and that was
because of the detailed nature of our functional spec…at the beginning
and so…if you want to see the full range of what’s available you need to
broaden your [specification]… (Group 1, Male, Pharmacist, hospital
in process of implementing)
System choice and writing functional specifications were further
perceived to be restricted by a limited knowledge of existing system
functionality amongst the NHS as well as a lack of resources to
actively seek out suppliers and spend time at reference sites.
…there’s a couple of systems that have lots of…sites using them but
most systems have very little experience and use and it’s quite hard to
equate that. And a lot of, it’s very hard to go and see all of those systems
and everything that’s out there because the local [hospital] can’t afford to
send you off to do all of that. (Group 2, Female, Project Manager,
hospital in process of implementing)
In order to address the issue surrounding financial restrictions,
hospital representatives suggested that existing resources (e.g.
relating to functional specifications, hazard assessments, imple-
mentation progress) should be pooled wherever possible and that
experiences and lessons learned as well as potential areas of risk
associated with different systems should be formally shared across
hospitals. Such sharing of experiences was however either non-
existent, leading to efforts being duplicated across locations, or was
taking place informally, leading to unequal access to information
across the health service.
Timescale and deliverability: planning the change whilst
maintaining strategic flexibility to respond to changing
needs and environments
Throughout the planning and implementation stages several
practical issues to be included in the business case related to
workflow and process mapping, stakeholder engagement, invest-
ment and resources, parallel paper and electronic systems and
interoperability, and the composition of the project team.
User workflow and process mapping was viewed as necessary to
provide a baseline from which the organizational strategy for
change could be developed. Participants argued that organizations
that were clear about current and expected organizational changes
to improve efficiencies tended to find it easier to choose an
appropriate system, plan for required resources, and keep to the
deliverables.
…given that prescribing is the most common intervention…it’s going to
come in at a multiple number of points in a workflow, not necessarily
just a prescribing workflow but admissions all the way through. And I
think if that was done more often, and in the procurements that I’ve seen
where organizations are very clear on how and what they want to deliver
it certainly helped them challenge the vendors to actually deliver more at
an earlier stage and be clear on what needs to come out of a solution.
(Group 1, Male, System developer)
Most hospital stakeholders were of the opinion that the amount
of resources required was often under-estimated when planning for
implementation. This was most commonly perceived to be
associated with implementation-related costs (as opposed to the
capital needed to buy the system itself).
… what we underestimate is the amount of money we have to spend on
implementation. We all think when you buy the system that’s
it…actually buying the system is just the beginning and I think we
constantly underestimate that…(Group 1, Female, Physician, hospital
planning to implement)
…the other two big things, one was interfacing, developing interfaces
and making things work between different systems and the other one was
the amount of operational time that’s needed, so a lot of clinical
pharmacy time that you wouldn’t include in your project costs and
probably nursing and clinical time. (Group 2, Female, Project
Manager, hospital in process of implementing)
In addition, and despite acknowledging that the business case
should be used as the central project planning vehicle, participants
emphasized that changing needs and environments required a
certain degree of flexibility. Those that had already implemented
for example stated that their needs had changed throughout
different stages of the journey.
… from where we started two and a half years ago it has changed
dramatically and the emphasis has changed and the priorities have
changed…(Group 1, Male, Project Manager, hospital in process of
implementing)
Some also stated that financial aspects of the business case may
need revision and refinement as more in-depth knowledge is
developed over time.
Business Case for Hospital Electronic Prescribing
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…you should write just a business case for the next stage which is your
procurement so it might start to touch on a lot of the areas but it
wouldn’t necessarily talk about financials because you wouldn’t know
about those so you couldn’t therefore do a proper financial business
case…So you’d probably look at it in terms of…reduction of clinical
risks and…the sort of non-financial things but I don’t know how you
could do a financial business case until you’ve done some of the later
work so the two sort of things need to almost go along side by side.
(Group 1, Male, Project Manager, hospital in process of implementing)
Timescale and deliverability: separating ‘‘wants and
aspirations’’ from organizational ‘‘needs’’
Managing expectations was mentioned frequently, with the
perception amongst many that most organizational stakeholders
over-estimated actual benefits and underestimated potential
adverse impacts of ePrescribing systems. This was perceived to
be particularly true in relation to costs and individual workloads
for end-users as these would, despite overall business gain, increase
for some end-users with implementation.
…so the benefit is not for the person who carries out the work so there’s
a transfer of work. Standards improve, people have to do more work and
the people who are doing the work are not the ones who see the immediate
benefit. (Group 1, Female, Physician, hospital planning to implement)
…in our [hospital] absolutely, it was money and it was seen as a
potential way of saving, you know, saving money….we haven’t been
able to show that yet…(Group 1, Male, Pharmacist, hospital in process
of implementing)
Currently, it was felt that especially among users, expectations
of what the system would be able to do often far exceeded reality,
with limited appreciation of the risks.
…part of the problem we had was that at the initial stages the
expectations of the clinicians and the nurses and the pharmacists of the
things that, the system we bought was going to be able to do was in no
way matched up to what we’ve got.…(Group 2, Female, Pharmacist,
hospital has implemented)
… we came out with a list, a huge great big long wish list and then
have ended up with a system that doesn’t achieve any of those things and
so the expectations are wildly different. The expectations of our
clinicians, a lot of them is that this is going to…solve lots and lots of
problems and it isn’t, and actually that makes the problems that it does
cause…more acute to them because that’s balancing the see-saw even
further in the other direction. (Group 1, Male, Pharmacist, hospital in
process of implementing)
In line with these high expectations, it was felt that many
hospital stakeholders had developed a ‘‘wish list’’ of system
features that developers were unable to fulfill. Therefore, it was
argued that organizations should conceptually separate ‘‘wants
and aspirations’’ from organizational needs, although this is clearly
not black and white. However, better prioritization could result in
more productive working relationships with developers as well as a
more efficient management of user expectations.
There’s like the must haves, the icing on the cake and things that would
be nice to come afterwards. (Group 2, Female, Project Manager,
hospital in process of implementing)
There are certain [features] which are very much aspirational, there are
certain ones which are must haves and there are certain ones that are a
bridge between those two ends of the spectrum and you need to be able to
migrate from the must haves into the aspirational wants if they’re still
relevant. (Group 2, Male, System developer)
It was further acknowledged that there could be adverse effects
associated with implementations and that these would need to be
anticipated, measured and managed. For instance, hospitals were
often forced to make ad-hoc and unanticipated system changes
due to systems presenting new unexpected safety risks:
…the spec said it ought to have everything else but it doesn’t and during
the roll out we’ve had to make difficult decisions about changing things
from a safety point of view as a result of things that have happened as
we’ve rolled out. And you need the ability to do that and to respond to
those quite quickly…(Group 1, Male, Pharmacist, Hospital in process
of implementing)
Discussion
We convened a wide variety of national stakeholders from
different professional backgrounds to understand some of the
challenges surrounding procurement and business case develop-
ment relating to ePrescribing, and identify possible strategies to
enhance the efficiency of these processes. Key findings were that
such organizational change initiatives should ideally be viewed as a
fundamental aspect of a wider organizational strategy, and
characterized by long-term partnerships within and between the
NHS and suppliers. Planning of financial resources and associated
local needs is vital, although the journey must also be character-
ized by some strategic flexibility as new needs emerge and
technologies develop over time. This also requires a realistic
appreciation of the benefits and trade-offs of such systems. Key
benefits were viewed as including: reductions in prescribing errors
and improved patient safety through decision support functionality
and legibility; improved quality of care through better access to
information and information flows; improved compliance with
clinical guidelines; and innovative secondary uses of data [29]. We
summarize possible efficiency enhancement strategies emerging
from this work in Table 5. Surprisingly, improved workflows and
efficiency were not cited as benefits, although observed in previous
work [8]. This may be due to the fact that systems discussed were
still at relatively early stages of implementation with limited scope
for customization.
When examining the literature surrounding information systems
more generally, there are several existing models postulating the
importance of the alignment (or fit) between business/organiza-
tional processes and IT systems [30–33]. Our findings resonate
with this body of work as organizational change initiatives
involving IT systems are increasingly being considered as an
intricate feature of wider organizational strategies and processes.
Our work has also illustrated the important inter-relationships
between organizational and technical considerations [32,33]. For
example, whilst strong leadership is likely to facilitate change [30],
this also needs to be cognizant of emergent technical opportunities
and choices and have an appreciation of how to embed these
systems into everyday care processes [33].
Others have evaluated a number of specific issues around
ePrescribing applications, including success factors for implemen-
tation and cost-effectiveness [8,19,34], impacts on medication
safety and potential to cause harm [35]. The UK is now at a key
Business Case for Hospital Electronic Prescribing
PLOS ONE | www.plosone.org 7 November 2013 | Volume 8 | Issue 11 | e79394
stage, as hospitals around the country are considering embarking
on this journey [6,36].
While the considerations raised in the discussions we evaluated
were not exhaustive, they provide a starting point for hospitals that
are planning to implement relevant systems. In doing so, they are
building on the important work conducted by NHS Connecting
for Health in 2009, outlining a list of questions that hospitals
should ask themselves before venturing forth with implementing
ePrescribing systems [28]. We offer a set of revised questions based
on the results of the present work in Table 6.
Care however needs to be taken in attempting to transfer
findings from this study to other contexts. This is because prior
work has highlighted the highly contextualized nature of
developing business cases and procurement processes of major
IT systems in complex organizational environments [9]. Conse-
quently, due to variations in need, demographics and strategies,
healthcare organizations are faced with having to translate these
somewhat abstract general concepts into concrete organizational
approaches. That said, there appear to be some transferable
dimensions to the development and execution of business cases,
which the information systems literature has begun to identify.
These include information on benefits, costs and risks, as well as
methods of measuring impacts [10,37–39], and can be used to
support deliberations surrounding making the case for change,
assessing capital and revenue implications, and risk analysis and
management (Table 1). More specifically in relation to ePrescrib-
ing systems (Table 1), we have attempted to identify potentially
transferable lessons in relation to strategic context (by outlining
prominent organizational strategies), case for change and objec-
tives (by beginning to gain insights into realistic benefits that can
be expected), future service requirements and options appraisal
(both of which can be facilitated by collaboration and networking
with other organizations and suppliers), capital and revenue
implications (by assessing necessary investments and resources),
timescale and deliverability (by maintaining a realistic expectation
of benefits and work required), and risk analysis and management
Table 5. Possible efficiency enhancement strategies emerging from this work.
Strategic context
Developing a clear roadmap of how ePrescribing fits in with the wider long-term organizational IT strategy. This should involve detailed mapping of required input from
and engagement of a wide range of organizational stakeholders beyond the pharmacy department. It should also include a realistic assessment/planning of anticipated
benefits and a recognition that these are likely to materialize in the medium- to long-term.
Case for change and objectives
System choice needs to emerge from this strategy and should be informed by a detailed appreciation of the needs of different stakeholders. Ongoing evaluation of
these needs through continuous engagement both prior to and after procurement is therefore vital. This requires an assessment of potential future scenarios relating to
both organizational vision and existing/future system functionality, as well as an assessment of strategic alignment between organizational strategies and available
systems.
Future service requirements and options appraisal
Longer-term relationships with suppliers can be greatly facilitated by discussing expectations on both sides in advance and agreeing on a common goal. This should
involve assessing desirable and essential functionality, but also potential technical and financial constraints. Shared risk registers tackling areas of particular importance
(e.g. resources, interoperability, changing needs) can be a good way of achieving this.
Networking with other healthcare organizations is essential. Designated individuals should be identified to frequently attend information sharing events and
conferences in order to make and maintain important contacts.
Timescale and deliverability
Tracking of system benefits needs to be conducted throughout planning, implementation and routine use. This should involve baseline measurements as well as
assessments of short-, medium- and longer-term benefits.
doi:10.1371/journal.pone.0079394.t005
Table 6. Questions that hospitals should ask themselves before venturing forth with implementing ePrescribing systems.
Strategic context
1. What is the overall organizational information strategy and how does ePrescribing fit into this in the short-, medium- and long-term?
Case for change and objectives
2. Which system and which supplier fits best within this information strategy?
3. Has the implementation necessary inter-disciplinary buy-in across the organization?
Future service requirements and options appraisal
4. How do hospital and supplier visions and short-, medium- and long-term strategies align?
5. Has anyone else implemented this system and what are their experiences? Ideally share experiences on an on-going basis.
6. What are current organizational processes, what is the desired future state (in the short-, medium- and long-term), and what steps need to be taken to get there?
7. What functionality can local resources realistically buy now and in the future? This will also require accounting for additional staff, infrastructure, interfacing etc.
Timescale and deliverability
8. What is essential functionality and what is desirable? This should involve assessing organizational and individual needs of each professional stakeholder group.
9. What are realistic organizational and individual benefits?
10. What changes to systems, needs and strategies can be expected in the future?
doi:10.1371/journal.pone.0079394.t006
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(through stakeholder engagement and meaningful work process
mapping).
A key strength of our efforts relates to the balance between
conducting methodologically sound and theoretically informed
research with high policy and clinical relevance. The work is likely
to be generalizable across NHS settings, but may have more
limited applicability to international health systems due to
variations in context. Nevertheless, there may be some transferable
lessons, particularly in relation to very large healthcare systems,
such as the Veterans Health Administration or Kaiser Permanente
in the US, or in relation to other health technologies. We have
brought together stakeholders from different backgrounds and
encouraged and facilitated frank discussion and debate in this
important, but hitherto largely neglected area. Naturally, there are
also limitations emerging from this balance. For example, our
facilitators were not trained qualitative researchers, but practi-
tioners with established credibility within the relevant stakeholder
groups, having previously worked within NHS Connecting for
Health. Similarly, the fact that discussions were recorded may
have inhibited some participants from disclosing important
information. It further became apparent that open discussion
was somewhat inhibited in groups where system suppliers and staff
from hospitals installing/using the same system were placed in one
discussion group, as certain statements were feared to be perceived
as potential criticism by some. In addition, the participants may
not have recognized all potential benefits, and may not have been
able to anticipate what their relative contributions would be. More
generally, the number of participants was small, which may have
resulted in limited insights relating to the range of different roles.
However, the relatively intimate format also allowed all partici-
pants to contribute to discussions and ensure that their views were
explored in depth.
Overall, our results have illustrated that implementation of
ePrescribing systems should not take place solely within the
pharmacy department – as is often perceived to be the case by
some organizational stakeholders in the UK [13]. This is because
these systems have a significant impact on provider time and they
are intricately associated with wider organizational processes and
strategies that involve changing workflows for a range of hospital
professionals. Organizations need to incorporate the implementa-
tion of ePrescribing within their strategic planning from the start in
order to ensure an integrated approach to improving safety and
efficiency. Equally, extra-organizational groupings such as suppli-
ers and other implementing organizations play an important role
in the realization of desired benefits and system development over
time. They therefore need to play a central role in organizational
activities surrounding the preparation of business cases for
ePrescribing systems. Networking with other implementing sites
and suppliers can not only help to disseminate lessons learned, but
also to ensure that systems are being developed in collaboration
and refined accordingly to suit the health system as a whole.
Our findings reinforce the assumption that technical, human
and organizational dimensions are situated within and influenced
by a larger environment including a web of other healthcare
organizations, industry stakeholders (e.g. system suppliers), the
media, governmental bodies and associated policy, professional
groups, and the general economic landscape [12,40–43]. The
literature shows how these associated factors can shape the
implementation of technology in important ways, and our work
highlights the need to extend these considerations to include the
early stages of the technology lifecycle, namely those that relate to
conception and planning of the technological change.
Conclusions
Developing business cases to justify investments is a central
component of planning for the implementation of ePrescribing
systems. The area is ripe for discussion and debate as the number
of English hospitals preparing themselves for procurement is
steadily increasing [36]. In order to facilitate efficiency and
maximize existing expertise, it is vital that business cases are built
on a solid foundation and that lessons are shared between settings
wherever possible. Building on previously identified potentially
transferable dimensions to the development and execution of
business cases surrounding measurements of costs/benefits and
risk management, we have begun to identify components of
ePrescribing system business cases that may facilitate this sharing.
The UK will also have to consider the experiences of other
countries around issues such as whether to link ePrescribing to
other types of ordering and what the potential benefits of
implementation of this technology will actually be.
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